← Leaderboards
Carrie German
Cfd Research Corporation
$4,777,127
Attributed
$5,545,919
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,146,148 · 6
FDA$399,771 · 1
By mechanism
R44$1,693,929 · 1
R01$1,537,585 · 1
UG3$1,048,481 · 1
R43$551,938 · 2
U01$399,771 · 1
R41$314,215 · 1
Top collaborators
- Neera Tewari-Singh4 shared
Others in their field
Other Emerging Leaders on “Evaluation”
- Valerie Koch · University Corporation For Atmospheric Res$265,601,376
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,645,551
- Beth Baseler · Leidos Biomedical Research, Inc.$208,220,586
- John E West · University Of Texas At Austin$131,399,667
- Kimberly Smith · Ppd Development Lp$115,671,664
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,805,377
Research focus
EvaluationOrganIn VivoTissuesToxic EffectTreatment StrategyExperimental StudyDesignLiquid SubstanceBiologicalReportingComputer ModelsInflammationIn SilicoEffective TherapyBiological MarkersLaboratoriesIn VitroIn Vivo EvaluationPharmaceutical PreparationsPhysiologicalAnimalsMicrofluidicsCells
Grant awards (13)
An Organ-on-Chip Approach to Evaluation of Reproductive Health, Aging and Disease inWomen$1,048,481
UG3 · FY2025 · TR · contact PI
Understanding Mustard Vesicants Distribution and Toxicity in the Eye Using In Vivo and In Silico Models$453,286
R01 · FY2025 · EY
Understanding Mustard Vesicants Distribution and Toxicity in the Eye Using In Vivo and In Silico Models$156,998
R01 · FY2025 · EY
A synergistic in vitro-in silico model of the placental barrier for predicting fetal exposure and toxicity of xenobiotic compounds$836,497
R44 · FY2024 · HD · contact PI
Understanding Mustard Vesicants Distribution and Toxicity in the Eye Using In Vivo and In Silico Models$460,271
R01 · FY2024 · EY
A synergistic in vitro-in silico model of the placental barrier for predicting fetal exposure and toxicity of xenobiotic compounds$857,432
R44 · FY2023 · HD · contact PI
Understanding Mustard Vesicants Distribution and Toxicity in the Eye Using In Vivo and In Silico Models$467,030
R01 · FY2023 · EY
Real-Time Quantitation of Transport Across Vascular-Tissue Interfaces in Organ-On-Chip Models Using In Situ Mass Spectrometry$314,215
R41 · FY2022 · GM · contact PI
An in vitro model for screening penetration of ocular drug products$300,000
R43 · FY2022 · EY · contact PI
Computational Biology (Cobi) Tools as a Framework for Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Extrapolation from Rabbit to Human for Ophthalmic Drug Products$39,849
U01 · FY2022 · FD · contact PI
Computational Biology (Cobi) Tools as a Framework for Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Extrapolation from Rabbit to Human for Ophthalmic Drug Products$179,978
U01 · FY2021 · FD · contact PI
A Synergystic In Vitro-In Silico Model of the Placental Barrier for Predicting Fetal Exposure and Toxicity of Xenobiotic Compounds$251,938
R43 · FY2020 · HD · contact PI
Computational Biology (Cobi) Tools as a Framework for Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Extrapolation from Rabbit to Human for Ophthalmic Drug Products$179,944
U01 · FY2020 · FD · contact PI